Skip to main content

Table 5 Factors that may influence medicines retail price of MPR > 2.5 in private healthcare sector in Malaysia

From: Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector

 

MPR

Univariate analysis (n = 2527)

Multivariate analysis (n = 2527)

MPR ≤ 2.5 (n = 202),

n (%)a

MPR > 2.5 (n = 2325),

n (%)a

Crude OR (95% CI)

Wald’s χ2 (df)

P-value

Adj. OR (95% CI)

Wald’s χ2 (df)

P-value

Condition

 Acute

99 (11.3)

774 (88.7)

1.00

  

1.00

  

 Chronic

103 (6.2)

1551 (93.8)

1.93 (1.44, 2.57)

19.76 (1)

<  0.001

2.05 (1.46, 2.70)

16.84 (1)

<  0.001

Type of medicine

 Innovator brands

32 (3.6)

851 (96.4)

1.00

  

1.00

  

 Generic

170 (10.3)

1474 (89.7)

0.33 (0.22, 0.48)

32.22 (1)

<  0.001

0.24 (0.15, 0.37)

39.81 (1)

<  0.001

Manufacturer

 Import

149 (8.8)

1542 (91.3)

1.00

  

1.00

  

 Local

53 (6.3)

783 (93.7)

1.43 (1.03, 1.98)

4.61 (1)

0.032

3.86 (2.61,5.71)

45.88 (1)

<  0.001

Region

 Peninsular

161 (8.7)

1686 (91.3)

1.00

  

1.00

  

 East Malaysia

41 (6.0)

639 (94.0)

1.49 (1.04, 2.12)

4.83 (1)

0.028

1.84 (1.26, 2.68)

10.32 (1)

<  0.001

Type of Facility

 Community Pharmacy

179 (8.3)

1984 (91.3)

1.00

     

 Private Hospital

23(6.3)

341 (93.7)

1.34 (0.85, 2.09)

1.61 (1)

0.200

Location

 Urban

152(7.1)

1975 (92.9)

1.00

  

1.00

  

 Rural

50(12.5)

350 (87.5)

0.54 (0.38, 0.76)

12.77 (1)

<  0.001

0.48 (0.34, 0.69)

15.86 (1)

<  0.001

Form

 Tablet

161(6.9)

2181 (93.1)

1.00

  

1.00

  

 Other form

41(22.2)

144 (77.8)

0.26 (0.18, 0.38)

47.95 (1)

<  0.001

0.20 (0.13, 0.32)

51.53 (1)

<  0.001

PSD Wholesale

5.94 d

15.70 e

1.58 (1.27, 1.96)

17.29 (1)

< 0.001

NS

PSD RRP

8.60 d

20.84 e

1.47 (1.25, 1.74)

20.96 (1)

< 0.001

1.52 (1.17, 1.98)

10.03 (1)

< 0.001

MPMS Wholesale

5.21 d

11.96 e

1.36 (1.09, 1.69)

7.17 (1)

0.001

0.72 (0.55, 0.93)

6.10 (1)

0.013

  1. Abbreviations: MPR median price range, OR odds ratio, CI Confidence interval, NS Non-significant, PSD Pharmaceutical Service Division, RRP Recommended Retail Price, MPMS Medicine PriceMonitoring Survey
  2. Notes: a The percentage is reported by row, adding up to 100% based on available information; d Median price over IRP; e IQR of price over IRP